Rajesh Kumar Grover
Rajesh Kumar Grover | |
---|---|
Born | India |
Occupation | Oncologist |
Awards | Padma Shri |
Rajesh Kumar Grover is an Indian oncologist and former director and chief executive officer of Delhi State Cancer Institute, New Delhi.[1][2] The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine.[3][4]
Dr Grover has over 50 scientific papers to his credit and has attended over 100 conferences and workshops in India and abroad. [5][6][7][8] Research Gate has published ten of his articles in their online repository.[9]
References
- ^ "Delhi State Cancer Institute". Delhi State Cancer Institute. 2014. Retrieved November 7, 2014.
- ^ "India Medical Times". India Medical Times. 2014. Retrieved November 7, 2014.
- ^ "Padma 2014". Press Information Bureau, Government of India. 25 January 2014. Retrieved October 28, 2014.
- ^ "Drug Today". Drug Today. 2014. Retrieved November 7, 2014.
- ^ "Delhi State Cancer Institute". Delhi State Cancer Institute. 2014. Retrieved November 7, 2014. [verification needed]
- ^ "India Medical Times". India Medical Times. 2014. Retrieved November 7, 2014. [verification needed]
- ^ "Padma 2014". Press Information Bureau, Government of India. 25 January 2014. Retrieved October 28, 2014. [verification needed]
- ^ "Drug Today". Drug Today. 2014. Retrieved November 7, 2014. [verification needed]
- ^ "CTRI". CTRI. 2011. Retrieved November 7, 2014. [verification needed]
Further reading
- Gargi Tikku; Dhruv Jain; Rajesh K Grover (October 2014). "Malignant proliferating trichilemmal tumor of the scalp masquerading as squamous cell carcinoma: A need for common awareness". Indian Journal of Pathology and Microbiology. 57 (4): 646–647. doi:10.4103/0377-4929.142705. PMID 25308032.
- R. K. Grover; Dhruv Jain (November 2014). "Re: Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? – Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database". European Urology. 66 (5): 967–968. doi:10.1016/j.eururo.2014.08.031. PMID 25763446.